Salvage treatment with anlotinib for advanced non‐small cell lung cancer

Di Wu,Jun Nie,Ling Dai,Weiheng Hu,Jie Zhang,Xiaoling Chen,Xiangjuan Ma,Guangming Tian,Jindi Han,Sen Han,Jieran Long,Yang Wang,Ziran Zhang,Jian Fang

Salvage treatment with anlotinib for advanced non‐small cell lung cancer

2019

Di Wu
Jun Nie
Ling Dai
Weiheng Hu
Jie Zhang
Xiaoling Chen
Xiangjuan Ma
Guangming Tian
Jindi Han
Sen Han
Jieran Long
Yang Wang
Ziran Zhang
Jian Fang

Background This real‐world study assessed the efficacy and toxicity of anlotinib as salvage treatment in Chinese patients with advanced non‐small cell lung cancer (NSCLC).

Keywords:

Pathology
Medicine
Cell
Internal medicine
Oncology
Lung cancer
Proportional hazards model
Univariate analysis
Confidence interval
Adverse effect
Hazard ratio
Chemotherapy
Survival analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations